Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1901-1910 of 2905 for cancer

Edit search filters
  1. Antiandrogen Therapy And Radiation Therapy With Or Without Docetaxel In Treating Patients With Prostate Cancer That Has Been Removed By Surgery

    Albert Lea, MN, Rochester, MN

  2. Allogeneic Stem Cell Transplantation for Patients with Severe Aplastic Anemia

    Rochester, MN

  3. A Study Of MCLA-128 In Patients With Solid Tumors Harboring An NRG1 Fusion

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Of Using Mesenchymal Stem Cells Developed From The Patients Own Fat Tissue For Reducing Hemodialysis Arteriovenous Fistula Failure

    Rochester, MN

  5. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study of the Response of Feelings, Plans, and Behaviors of People after Learning Outcomes of Genetic Research

    Rochester, MN

  7. Compassionate Use Of Lorlatinib:PF-06463922 For Male Patient

    Rochester, MN

  8. A Study To Evaluate Topical VT30 To Treat Patients With Venous/Lymphatic Malformations Associated With PIK3CA Or TEK Gene Mutations

    Rochester, MN

  9. A Study To Evaluate Adverse Events And Change In Disease Activity Of Intravenous ABBV-706 Versus Standard Of Care In Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

  10. Testing A Standardized Approach To Surgery And Chemotherapy For Type I Pleuropulmonary Blastoma Or The Addition Of An Anti-cancer Drug, Topotecan, To The Usual Treatment For Types II And III Pleuropulmonary Blastoma

    Rochester, MN

.

Mayo Clinic Footer